Sadiq MA, Hassan M, Agarwal A, Sarwar S, Toufeeq S, Soliman MK, et al. Endogenous endophthalmitis: diagnosis, management, and prognosis. J Ophthalmic Inflamm Infect. 2015;5:32.
Maling S, King C, Davies N. A British ophthalmological surveillance unit study on metastatic endogenous endophthalmitis. Eye. 2018;32:743–8.
Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30:597–613.
Gajdzis M, Figuła K, Kamińska J, Kaczmarek R. Endogenous endophthalmitis-the clinical significance of the primary source of infection. J Clin Med. 2022;11:1183.
Connell PP, O’neill EC, Fabinyi D, Islam FM, Buttery R, McCombe M, et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye. 2011;25:66–72.
Danielescu C, Anton N, Stanca HT, Munteanu M. Endogenous endophthalmitis: a review of case series published between 2011 and 2020. J Ophthalmol. 2020;2020:8869590.
Sridhar J, Flynn Jr HW, Kuriyan AE, Miler D, Albini T. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013;3:60.
Vilela RC, Vilela L, Vilela P, Vilela R, Motta R, Pôssa AP, et al. Etiological agents of fungal endophthalmitis: diagnosis and management. Int Ophthalmol. 2014;34:707–21.
Chien KH, Huang KH, Chung CH, Hsieh YH, Liang CM, Chang YH, et al. The impact of diabetes mellitus medication on the incidence of endogenous endophthalmitis. PLoS ONE. 2020;15:e0227442.
Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. Am J Ophthalmol. 2015;159:498–504.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2023: trends and developments. 2023. https://www.emcdda.europa.eu/publications/european-drug-report/2023_en
de Esteban Maciñeira E, Bande MF, Soberanes-Perez JI, Paniagua L, Golzarri MF, Fromow-Guerra J, et al. Two-decade retrospective analysis of endogenous endophthalmitis in Spain and Mexico: a comprehensive study. J Clin Med. 2024;13:4990.
Ros-Sánchez E, Oliver-Gutierrez D, Buck P, Goncharova T, Distefano L, Kirkegaard-Biosca E, et al. Purpureocillium lilacinum-related endophthalmitis: case report. J Ophthalmic Inflamm Infect. 2024;14:27.
Thompson KN, Alshaikhsalama AM, Wang AL. Evaluation of the clinical course of endogenous endophthalmitis. J Vitreoretin Dis. 2023;7:389–96.
Breazzano MP, Bond III JB, Bearelly S, Kim DH, Donahue SP, Lum F, et al. American Academy of Ophthalmology. American Academy of Ophthalmology recommendations on screening for endogenous Candida endophthalmitis. Ophthalmology. 2022;129:73–76.
Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;153:162–6.e1.
Lamaris GA, Esmaeli B, Chamilos G, Desai A, Chemaly RF, Raad II, et al. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis. 2008;27:343–47.
Silpa-Archa S, Ponwong A, Preble JM, Foster CS. Culture-positive endogenous endophthalmitis: an eleven-year retrospective study in the central region of Thailand. Ocul Immunol Inflamm. 2018;26:533–42.
Wu ZH, Chan RP, Luk FO, Liu DT, Chan CK, Lam DS, et al. Review of clinical features, microbiological spectrum, and treatment outcomes of endogenous endophthalmitis over an 8-year period. J Ophthalmol. 2012;2012:265078.
Dedieu D, Contejean A, Gastli N, Marty-Reboul J, Poupet H, Brezin A, et al. Endogenous endophthalmitis: new insights from a 12-year cohort study. Int J Infect Dis. 2024;146:107116.
Feng HL, Robbins CB, Fekrat S. A nine-year analysis of practice patterns, microbiologic yield, and clinical outcomes in cases of presumed infectious endophthalmitis. Ophthalmol Retin. 2020;4:555–59.
Ratra D, et al. Endogenous endophthalmitis: a 10-year retrospective study at a tertiary hospital in South India. Asia Pac J Ophthalmol. 2015;4:286–92.
Nakhwa C. Endogenous fungal endophthalmitis treated with intravitreal caspofungin in a COVID-19 recovered patient: a case report. Indian J Ophthalmol. 2021;69:3759–61.
Garrido-Marin M, Kirkegaard Biosca E, Boixadera A, Fischer Fernandez R, Sánchez Vela L, Pardo Aranda A, et al. Multiresistant Candida endophthalmitis treated with intravitreal caspofungin: a case report. Ocul Immunol Inflamm. 2024;32:858–62.
Zhang YQ, Wang WJ. Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina. 2005;25:746–50.
Sallam A, Taylor SR, Khan A, McCluskey P, Lynn WA, Manku K, et al. Factors determining visual outcome in endogenous Candida endophthalmitis. Retina. 2012;32:1129–34.
Sheu SJ, Kung YH, Wu TT, Chang FP, Horng YH. Risk factors for endogenous endophthalmitis secondary to Klebsiella pneumoniae liver abscess: 20-year experience in Southern Taiwan. Retina. 2011;31:2026–31.
Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol. 2014;59:627–35.
